Finovate Renews Collaboration with IBN’s NetworkNewsWire for FinovateSpring 2024
April 17, 2024 09:35 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- via InvestorWire -- NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company powered by IBN (“InvestorBrandNetwork”), is proud to...
IBN Announces the Latest Episode of The GotStocks Podcast featuring Vision Marine Technologies Inc. (NASDAQ: VMAR)
February 16, 2024 13:12 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- via NetworkNewsWire — IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
Vision Marine Technologies Inc. (NASDAQ: VMAR) at Threshold of Major Market Boom in Boating Space
February 16, 2024 08:30 ET
|
Vision Marine Technologies Inc.
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Vision Marine Technologies Inc. (NASDAQ: VMAR) announces the availability of a broadcast titled, “The Electrifying Rise of Electric...
Vision Marine Technologies Inc. (NASDAQ: VMAR) ‘Disruptive Force’ in Electrification of Recreational Boating
February 15, 2024 10:01 ET
|
Vision Marine Technologies Inc.
NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Vision Marine Technologies Inc. (NASDAQ: VMAR) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one...
Finovate Again Engages IBN’s NetworkNewsWire for FinovateEurope 2024
January 26, 2024 09:35 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- NetworkNewsWire (NNW), a comprehensive financial news and publishing company powered by the IBN (InvestorBrandNetwork) platform, is delighted to announce...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
January 11, 2024 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Exciting New Cures Possible from GLP-1...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
January 09, 2024 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...
IBN to Serve as Corporate Communications Firm for Informa’s QuantMinds International, NetworkNewsWire Named Official Newswire
November 10, 2023 09:35 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- IBN (“InvestorBrandNetwork”), a pioneering corporate communications firm and content distributor, is delighted to announce that NetworkNewsWire (“NNW”)...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
November 01, 2023 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Can Diabetes, Weight-Loss Drugs Get Even...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs
October 31, 2023 08:31 ET
|
Lexaria Bioscience Corp.
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...